Key findings from the report include:
- Heart attacks are rising among younger people across the Asia-Pacific markets examined.
- Heart disease is costing the Asia-Pacific markets USD 46.3 billion (estimated across Australia, mainland China, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand).
- CVD policies do exist in some form in all economies studied, however there is substantial room for improvement.
- Policies on modifiable risk factors exist, but the success of translating these into legislation and action, along with measuring impact, remains to be defined.
- Only one market (Australia) has implemented a comprehensive secondary prevention of CVD public health awareness campaign.
- Clinical practice guidelines for CVD secondary prevention, heart attack and stroke, vary substantially across economies.
- Government audits are lacking. Only two study economies have any form of audit in place.
- Integrated primary care systems are still emerging in many Asian economies, and in many cases, patient uptake of services remains low.
Information contained in the Toolkit includes:
- An introduction to the HLM 2018
- Information about the latest global CVD targets
- Practical advice on how to advocate for CVD
- Key CVD advocacy opportunities and insights
- Helpful tools, websites and resources